Stocks and Investing
Stocks and Investing
Fri, June 22, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 21, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Skorney Maintained (SRPT) at Buy with Increased Target to $202 on, Jun 21st, 2018
Brian Skorney of Baird, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $120 to $202 on, Jun 21st, 2018.
Brian has made no other calls on SRPT in the last 4 months.
There are 8 other peers that have a rating on SRPT. Out of the 8 peers that are also analyzing SRPT, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $163 on, Wednesday, June 20th, 2018
- Hartaj Singh of "Oppenheimer" Downgraded from Buy to Hold on, Friday, May 4th, 2018
These are the ratings of the 6 analyists that currently disagree with Brian
- Joseph Schwartz of "Leerink Swann" Maintained at Buy with Increased Target to $196 on, Wednesday, June 20th, 2018
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $267 on, Tuesday, June 19th, 2018
- Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $120 on, Friday, June 15th, 2018
- Gena Wang of "Barclays" Upgraded from Hold to Buy on, Friday, May 11th, 2018
- Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $92 on, Friday, May 4th, 2018
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $95 on, Wednesday, March 14th, 2018